Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Pf, Ferrucci"'
Autor:
Clara NERVI, Ff, Ferrara, Fanelli M, Rippo MR, Tomassini B, Pf, Ferrucci, Ruthardt M, Gelmetti V, Gambacorti-Passerini C, Diverio D, Grignani F, Pg, Pelicci, Testi R
Publikováno v:
Europe PubMed Central
All-trans-retinoic acid (RA) treatment induces morphological remission in acute promyelocytic leukemia (APL) patients carrying the t(15;17) and expressing the PML/RARalpha product by inducing terminal differentiation of the leukemic clone. RA treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::be973cbd2fc4605748c207b7251642a1
https://pubmed.ncbi.nlm.nih.gov/9746761
https://pubmed.ncbi.nlm.nih.gov/9746761
Autor:
Macandog ADG; Department of Experimental Oncology, Istituto Europeo di Oncologia-IRCCS, Milan 20139, Italy., Catozzi C; Department of Experimental Oncology, Istituto Europeo di Oncologia-IRCCS, Milan 20139, Italy., Capone M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples 80131, Italy., Nabinejad A; Department of Experimental Oncology, Istituto Europeo di Oncologia-IRCCS, Milan 20139, Italy., Nanaware PP; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY 10065, USA., Liu S; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104-4238, USA., Vinjamuri S; Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612-7342, USA., Stunnenberg JA; Netherlands Cancer Institute (NKI)-AVL, North Holland, Amsterdam 1066 CX, the Netherlands., Galiè S; Department of Experimental Oncology, Istituto Europeo di Oncologia-IRCCS, Milan 20139, Italy., Jodice MG; Department of Experimental Oncology, Istituto Europeo di Oncologia-IRCCS, Milan 20139, Italy., Montani F; Department of Experimental Oncology, Istituto Europeo di Oncologia-IRCCS, Milan 20139, Italy., Armanini F; Department of CIBIO, University of Trento, Trento, Povo 38123, Italy., Cassano E; Department of Experimental Oncology, Istituto Europeo di Oncologia-IRCCS, Milan 20139, Italy., Madonna G; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples 80131, Italy., Mallardo D; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples 80131, Italy., Mazzi B; Ospedale San Raffaele IRCCS, Milan 20132, Italy., Pece S; Department of Experimental Oncology, Istituto Europeo di Oncologia-IRCCS, Milan 20139, Italy., Tagliamonte M; Innovative Immunological Models, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples 80131, Italy., Vanella V; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples 80131, Italy., Barberis M; Department of Experimental Oncology, Istituto Europeo di Oncologia-IRCCS, Milan 20139, Italy., Ferrucci PF; Ospedale MultiMedica San Giuseppe, Milan 20132, Italy., Blank CU; Netherlands Cancer Institute (NKI)-AVL, North Holland, Amsterdam 1066 CX, the Netherlands., Bouvier M; Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612-7342, USA., Andrews MC; Department of Medicine, School of Translational Medicine, Monash University, Melbourne, VIC 3004, Australia., Xu X; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104-4238, USA., Santambrogio L; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY 10065, USA., Segata N; Department of Experimental Oncology, Istituto Europeo di Oncologia-IRCCS, Milan 20139, Italy; Department of CIBIO, University of Trento, Trento, Povo 38123, Italy., Buonaguro L; Innovative Immunological Models, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples 80131, Italy., Cocorocchio E; Department of Experimental Oncology, Istituto Europeo di Oncologia-IRCCS, Milan 20139, Italy., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples 80131, Italy., Manzo T; Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy., Nezi L; Department of Experimental Oncology, Istituto Europeo di Oncologia-IRCCS, Milan 20139, Italy. Electronic address: luigi.nezi@ieo.it.
Publikováno v:
Cell host & microbe [Cell Host Microbe] 2024 Nov 13; Vol. 32 (11), pp. 2004-2018.e9. Date of Electronic Publication: 2024 Oct 30.
Autor:
Zager JS; Departments of Cutaneous Oncology and Sarcoma, Moffitt Cancer Center, Tampa, FL, USA. Jonathan.Zager@moffitt.org.; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA. Jonathan.Zager@moffitt.org., Orloff M; Thomas Jefferson University, Philadelphia, PA, USA., Ferrucci PF; European Institute of Oncology, IRCCS, Milan, Italy., Choi J; Departments of Cutaneous Oncology and Sarcoma, Moffitt Cancer Center, Tampa, FL, USA.; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA., Eschelman DJ; Thomas Jefferson University, Philadelphia, PA, USA., Glazer ES; The University of Tennessee Health Science Center, Memphis, TN, USA., Ejaz A; The Ohio State University, Columbus, OH, USA., Howard JH; University of South Alabama, Mobile, AL, USA., Richtig E; Medical University of Graz, Graz, Austria., Ochsenreither S; Charité Comprehensive Cancer Center, Berlin, Germany., Reddy SA; Stanford University, Stanford, CA, USA., Lowe MC; Emory University, Atlanta, GA, USA., Beasley GM; Duke University, Durham, NC, USA., Gesierich A; University Hospital Würzburg, Würzburg, Germany., Bender A; University Hospital Marburg, Marburg, Germany., Gschnell M; University Hospital Marburg, Marburg, Germany., Dummer R; University Hospital Zürich, Zürich, Switzerland., Rivoire M; Léon Bérard Center, Lyon, France., Arance A; Hospital Clínic Barcelona, Barcelona, Spain., Fenwick SW; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Sacco JJ; The Clatterbridge Cancer Center, University of Liverpool, Liverpool, UK., Haferkamp S; University Hospital Regensburg, Regensburg, Germany., Weishaupt C; University Hospital Münster, Münster, Germany., John J; Delcath Systems, Inc., Queensbury, NY, USA., Wheater M; University Hospital Southampton NHS Foundation Trust, Southampton, UK., Ottensmeier CH; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2024 Nov; Vol. 31 (12), pp. 8262-8263.
Autor:
Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS Fondazione 'G. Pascale,' Napoli, Italy., Mandalà M; Department of Oncologic, Hematologic, Gastroenterological Sciences, University of Perugia, Perugia, Italy.; Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy., Ferrucci PF; Oncology Department Director, Ospedale San Giuseppe, MultiMedica Group, IRCCS, Milan., Guidoboni M; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori 'Dino Amadori,' Meldola, Italy., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska Curie National Research Institute of Oncology, 02-781, Warsaw, Poland., Ferraresi V; Sarcomas and Rare Tumors Departmental Unit, IRCCS Regina Elena National Cancer Institute, Rome., Arance A; Department of Medical Oncology and IDIBAPS, Hospital Clínic Barcelona, Barcelona., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori 'Giovanni Paolo II,' Bari, Italy., Maiello E; Oncology Unit, Foundation IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Gogas H; First Department of Medicine, National and Kapodistrian University of Athens, Athens., Richtig E; Department of Dermatology, Medical University of Graz, Graz, Austria., Quaglino P; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy., Lebbé C; Université Paris Cite, Dermato-Oncology and CIC AP-HP Hôpital Saint Louis, Cancer Institute APHP, Nord-Université Paris Cite, INSERM U976, Paris., Helgadottir H; Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm., Queirolo P; Skin Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Division of Melanoma, Sarcomas and Rare Tumors, IRCCS European Institute of Oncology, Milan., Spagnolo F; Skin Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genova, Italy., Tucci M; Department of Interdisciplinary Medicine, Oncology Unit, University of Bari 'Aldo Moro,' Bari, Italy., Del Vecchio M; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan., Gonzalez-Cao M; Department of Medical Oncology, Oncology Institute Rosell, University Hospital Dexeus, Barcelona., Minisini AM; Academic Hospital 'Santa Maria della Misericordia,' Azienda Sanitaria Universitaria del Friuli Centrale, Udine, Italy., De Placido S; Department of Clinical Medicine and Surgery, University of Naples 'Federico II,' Naples, Italy., Sanmamed MF; Department of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Casula M; Immuno-Oncology & Targeted Cancer Biotherapies, Unit of Cancer Genetics, University of Sassari, IRGB-CNR, 07100 Sassari, Italy., Bulgarelli J; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori 'Dino Amadori,' Meldola, Italy., Pisano M; Immuno-Oncology & Targeted Cancer Biotherapies, Unit of Cancer Genetics, University of Sassari, IRGB-CNR, 07100 Sassari, Italy., Piccinini C; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori 'Dino Amadori,' Meldola, Italy., Piccin L; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Cossu A; Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy., Mallardo D; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS Fondazione 'G. Pascale,' Napoli, Italy., Paone M; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS Fondazione 'G. Pascale,' Napoli, Italy., Vitale MG; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS Fondazione 'G. Pascale,' Napoli, Italy., Melero I; Department of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Grimaldi AM; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS Fondazione 'G. Pascale,' Napoli, Italy.; Medical Oncology Unit, AORN San Pio, Benevento, Italy., Giannarelli D; Facility of Epidemiology and Biostatistics, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome., Palmieri G; Immuno-Oncology & Targeted Cancer Biotherapies, Unit of Cancer Genetics, University of Sassari, IRGB-CNR, 07100 Sassari, Italy., Dummer R; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Sileni VC; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
Publikováno v:
NEJM evidence [NEJM Evid] 2024 Oct; Vol. 3 (10), pp. EVIDoa2400087. Date of Electronic Publication: 2024 Sep 24.
Autor:
Zager JS; Departments of Cutaneous Oncology and Sarcoma, Moffitt Cancer Center, Tampa, FL, USA. Jonathan.Zager@moffitt.org.; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA. Jonathan.Zager@moffitt.org., Orloff M; Thomas Jefferson University, Philadelphia, PA, USA., Ferrucci PF; European Institute of Oncology, IRCCS, Milan, Italy., Choi J; Departments of Cutaneous Oncology and Sarcoma, Moffitt Cancer Center, Tampa, FL, USA.; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA., Eschelman DJ; Thomas Jefferson University, Philadelphia, PA, USA., Glazer ES; The University of Tennessee Health Science Center, Memphis, TN, USA., Ejaz A; The Ohio State University, Columbus, OH, USA., Howard JH; University of South Alabama, Mobile, AL, USA., Richtig E; Medical University of Graz, Graz, Austria., Ochsenreither S; Charité Comprehensive Cancer Center, Berlin, Germany., Reddy SA; Stanford University, Stanford, CA, USA., Lowe MC; Emory University, Atlanta, GA, USA., Beasley GM; Duke University, Durham, NC, USA., Gesierich A; University Hospital Würzburg, Würzburg, Germany., Bender A; University Hospital Marburg, Marburg, Germany., Gschnell M; University Hospital Marburg, Marburg, Germany., Dummer R; University Hospital Zürich, Zürich, Switzerland., Rivoire M; Léon Bérard Center, Lyon, France., Arance A; Hospital Clínic Barcelona, Barcelona, Spain., Fenwick SW; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Sacco JJ; The Clatterbridge Cancer Center, University of Liverpool, Liverpool, UK., Haferkamp S; University Hospital Regensburg, Regensburg, Germany., Weishaupt C; University Hospital Münster, Münster, Germany., John J; Delcath Systems, Inc., Queensbury, NY, USA., Wheater M; University Hospital Southampton NHS Foundation Trust, Southampton, UK., Ottensmeier CH; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2024 Aug; Vol. 31 (8), pp. 5340-5351. Date of Electronic Publication: 2024 May 04.
Autor:
Di Giacomo AM; University of Siena, Siena, Italy; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; NIBIT Foundation Onlus, Italy. Electronic address: annamaria.digiacomo@unisi.it., Chiarion-Sileni V; Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Del Vecchio M; Unit of Melanoma, Medical Oncology, Department of Medical Oncology and Hematology, Istituto Nazionale dei Tumori, Milan, Italy., Ferrucci PF; Department of Oncology Gruppo Multimedica, Milan, Italy., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Quaglino P; Dermatology Clinic, Department of Medical Science, University of Turin, Italy., Guidoboni M; University of Ferrara, Italy., Marchetti P; IRCCS IDI-Istituto Dermopatico dell'Immacolata, 00167, Rome, Italy., Simonetti E; University of Siena, Siena, Italy., Santangelo F; University of Siena, Siena, Italy., Amato G; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy., Covre A; University of Siena, Siena, Italy., Camerini R; NIBIT Foundation Onlus, Italy., Valente M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy., Mandalà M; University of Perugia, Santa Maria della Misericordia, University Hospital of Perugia, Italy., Giannarelli D; Statistics, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy., Calabrò L; University of Ferrara, Italy., Maio M; University of Siena, Siena, Italy; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; NIBIT Foundation Onlus, Italy.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 113981. Date of Electronic Publication: 2024 Mar 09.
Autor:
Di Giacomo AM; University of Siena, Siena, Italy; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; NIBIT Foundation Onlus, Italy. Electronic address: annamaria.digiacomo@unisi.it., Chiarion-Sileni V; Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Del Vecchio M; Unit of Melanoma, Medical Oncology, Department of Medical Oncology and Hematology, Istituto Nazionale dei Tumori, Milan, Italy., Ferrucci PF; Department of Oncology Gruppo Multimedica, Milan, Italy., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Quaglino P; Dermatology Clinic, Department of Medical Science, University of Turin, Italy., Guidoboni M; University of Ferrara, Italy., Marchetti P; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy., Simonetti E; University of Siena, Siena, Italy., Santangelo F; University of Siena, Siena, Italy., Amato G; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy., Covre A; University of Siena, Siena, Italy., Camerini R; NIBIT Foundation Onlus, Italy., Valente M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy., Mandalà M; University of Perugia, Santa Maria della Misericordia, University Hospital of Perugia, Italy., Giannarelli D; Statistics, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy., Calabrò L; University of Ferrara, Italy., Maio M; University of Siena, Siena, Italy; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; NIBIT Foundation Onlus, Italy.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Mar; Vol. 199, pp. 113531. Date of Electronic Publication: 2024 Jan 11.
Autor:
Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics. I.N.T. IRCCS Fondazione 'G. Pascale', Napoli, Italy. p.ascierto@istitutotumori.na.it., Casula M; Immuno-Oncology & Targeted Cancer Biotherapies, University of Sassari - Unit of Cancer Genetics, IRGB-CNR, 07100, Sassari, Italy., Bulgarelli J; Immunotherapy, Cell Therapy Unit and Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Pisano M; Immuno-Oncology & Targeted Cancer Biotherapies, University of Sassari - Unit of Cancer Genetics, IRGB-CNR, 07100, Sassari, Italy., Piccinini C; Immunotherapy, Cell Therapy Unit and Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Piccin L; Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Cossu A; Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy., Mandalà M; University of Perugia, Perugia, Italy.; Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy., Ferrucci PF; Biotherapy of Tumors Unit, Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy., Guidoboni M; Immunotherapy, Cell Therapy Unit and Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska Curie National Research Institute of Oncology, 02-781 -, Warsaw, Poland., Ferraresi V; Department of Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Arance A; Department of Medical Oncology, Hospital Clínic Barcelona, 08036, Barcelona, Spain., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori 'Giovanni Paolo II', Bari, Italy., Maiello E; Oncology Unit, Foundation IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Gogas H; First Department of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Richtig E; Department of Dermatology, Medical University of Graz, Graz, Austria., Fierro MT; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy., Lebbe C; Dermato-Oncology and CIC AP-HP Hôpital Saint Louis,Cancer Institute APHP. Nord-Université Paris Cite F-75010, Paris, INSERM U976, France., Helgadottir H; Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden., Queirolo P; Skin Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Division of melanoma Sarcoma and Rare Tumors, IRCCS European Institute of Oncology, Milan, Italy., Spagnolo F; Skin Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Tucci M; Department of Interdisciplinary Medicine, Oncology Unit, University of Bari 'Aldo Moro', Bari, Italy., Del Vecchio M; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cao MG; Department of Medical Oncology, University Hospital Dexeus, Barcelona, Spain., Minisini AM; Academic Hospital 'Santa Maria della Misericordia', Udine, Italy., De Placido S; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy., Sanmamed MF; Department of Interdisciplinary Medicine, Oncology Unit, University of Bari 'Aldo Moro', Bari, Italy., Mallardo D; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics. I.N.T. IRCCS Fondazione 'G. Pascale', Napoli, Italy., Paone M; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics. I.N.T. IRCCS Fondazione 'G. Pascale', Napoli, Italy., Vitale MG; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics. I.N.T. IRCCS Fondazione 'G. Pascale', Napoli, Italy., Melero I; Department of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Grimaldi AM; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics. I.N.T. IRCCS Fondazione 'G. Pascale', Napoli, Italy.; Medical Oncology Unit, AORN San Pio, Benevento, Italy., Giannarelli D; Fondazione Policlinico Universitario A. Gemelli, IRCCS - Facility of Epidemiology and Biostatistics, Rome, Italy., Dummer R; Department of Dermatology, University and University Hospital Zurich, Zurich, Switzerland., Sileni VC; Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Palmieri G; Immuno-Oncology & Targeted Cancer Biotherapies, University of Sassari - Unit of Cancer Genetics, IRGB-CNR, 07100, Sassari, Italy.
Publikováno v:
Nature communications [Nat Commun] 2024 Jan 02; Vol. 15 (1), pp. 146. Date of Electronic Publication: 2024 Jan 02.
Autor:
Marocchi F; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Palluzzi F; Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Nicoli P; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Melixetian M; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Lovati G; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Bertalot G; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy; Unità Operativa Multizonale di Anatomia Patologica, Azienda Provinciale per i Servizi Sanitari, Trento, Italy; CISMED - Centre for Medical Sciences, University of Trento, Trento, Italy., Pece S; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Ferrucci PF; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Bossi D; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy; Institute of Oncology Research, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Lanfrancone L; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy. Electronic address: luisa.lanfrancone@ieo.it.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2023 Oct; Vol. 143 (10), pp. 1993-2006.e10. Date of Electronic Publication: 2023 Mar 31.
Autor:
Ascierto PA; Unit of Melanoma and Innovative Therapies, IRCCS Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy., Di Giacomo AM; University of Siena and Center for Immuno-Oncology, University Hospital Le Scotte, Siena, Italy., Chiarion Sileni V; Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Queirolo P; Division of Melanoma Sarcoma and Rare Tumors, IRCCS European Institute of Oncology, Milano, Italy; IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy; Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate (DISC), Università degli Studi di Genova, Genova, Italy., Spagnolo F; IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy; Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate (DISC), Università degli Studi di Genova, Genova, Italy., De Galitiis F; Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy., Cognetti F; Regina Elena Institute, Rome, Italy., Mandalà M; University of Perugia, Perugia, Italy; Ospedale Papa Giovanni XXIII, Bergamo, Italy., Guidoboni M; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori 'Dino Amadori', Meldola, Italy., Rinaldi G; Department of Surgical, Oncological and Oral Sciences, Unità Operativa Complessa Medical Oncology, Policlinico Universitario Paolo Giaccone, Palermo, Italy., Depenni R; Department of Oncology and Hematology, Università degli Studi di Modena e Reggio Emilia, Modena, Emilia-Romagna, Italy., Consoli F; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology Unit, University of Brescia, ASST Spedali Civili, Brescia, Italy., Troiani T; University of Campania Luigi Vanvitelli, Napoli, Italy., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy., Marconcini R; Medical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Ferrucci PF; Biotherapy of Tumors Unit, Department of Experimental Oncology, European Institute of Oncology IRCCS, Milano, Italy., Strippoli S; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy., Fava P; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy., Merelli B; Ospedale Papa Giovanni XXIII, Bergamo, Italy., Simeone E; Unit of Melanoma and Innovative Therapies, IRCCS Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy., Di Guardo L; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Giannarelli D; Biostatistic, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Maio M; University of Siena and Center for Immuno-Oncology, University Hospital Le Scotte, Siena, Italy., Quaglino P; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy. Electronic address: pietro.quaglino@unito.it., Del Vecchio M; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Sep; Vol. 191, pp. 113246. Date of Electronic Publication: 2023 Jul 19.